AVENTURA, Fla., Nov. 3, 2011 /PRNewswire/ -- Double Eagle Holdings, Ltd. (OTCQB: DROP) today announced its intent to change the name of the company to Fuse Science, Inc. (www.fusescience.com) upon approval by the U.S. Securities and Exchange Commission. The company will begin trading under its new ticker symbol, DROP, at the market open today.
(Logo: http://photos.prnewswire.com/prnh/20110615/CL20255LOGO)
Fuse Science has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly. This is done in a concentrated "DROP" form that is simply applied under the tongue.
"As I've stated previously, we have high confidence that our proprietary technology can effectively produce aspirin in 'DROP' form, OTC medications, energy and electrolyte products, sleep aids, appetite suppressants, pharmaceutical medications including enhancement products like Viagra and Cialis, along with children's vitamins and complex nutrition products," said Brian Tuffin, Fuse Science President and Chief Operating Officer. "For the first time, complete product formulations that bypass the gastrointestinal tract and enter the blood stream directly can be created – producing virtually immediate product results."
The Fuse Science technology significantly accelerates conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.
"As a company, we are very focused on the commercialization and licensing of this DROP technology based upon the significant benefits that can be provided in several global product categories. The change of our ticker symbol to DROP is such a relevant and appropriate complement to our branding strategy," added Tuffin. "We look forward to leveraging our new market identity to generate continued shareholder interest and value – and to effectively communicate the practical benefits of our ground-breaking technology."
Fuse Science previously traded under the ticker symbol DEGH.
About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP) is an innovative consumer products company based in Aventura, Florida. Fuse Science's proprietary delivery and conveyance technologies are poised to redefine how consumers receive energy, medicines, vitamins and minerals, delivering their benefits faster and more effectively than ever before. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article